Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Organigram Global Inc.

Stage 4 · Declining · week 11→4 today

As of Oct 22, 2026, Organigram Global is in Stage 4, the downtrend phase, now in its first week (since Oct 22, 2026). It closed at $0.94, 55.6% below its 52-week high and below its 200-day average, which is falling.

Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. More about the company

$0.94
-0.38% today
$135M · Micro cap
Market Neutral — Fading

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is OGI early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 19w
S4 27w
S2 16w
S4 24w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S4 19w → S1 6w → S2 13w → S3 12w → S4 4w → S1 11w → S4 27w → S1 9w → S2 16w → S3 10w → S2 2w → S3 3w → S4 24w → S1 8w → S4 1w current
Total tracked: 165 weeks across 15 stage runs.

OGI among Drug Manufacturers - Specialty & Generic59th of 84 by relative strength

All 84 →
Stocks in Drug Manufacturers - Specialty & Generic ranked by relative strength, with stage and one-month change
#StockStageRS1M
1CPIXStage 2 · wk 2398+6.8%
2ETONStage 2 · wk 3097−10.1%
3ANIKStage 2 · wk 1596+3.5%
4IRWDStage 3 · wk 396−16.4%
5TEVAStage 2 · wk 995+3.1%
6AMRXStage 2 · wk 1995+5.9%
7KNSAStage 2 · wk 7395+6.2%
8AMLXStage 2 · wk 1593−6.6%
…59OGIStage 4 · wk 125−14.0%
vs 52W High
-55.6%
$0.87 lo$2.11 hi
55.6% below 52W high, deep Stage 4 damage
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 1
1w13w26w
Week 1, early Stage 4 decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-23.4%
200 DMA: $1.22 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.81x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-14.0%
3M
+0.2%
6M
-34.7%
YTD
-45.8%
1Y
-45.5%
Scan Membership
Breakout Watch
Latest: 2024-02-08
3 appearances in last 60 days. First seen: 2021-01-26.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S41→4
Wk 1 · Vol 0.81x
2026-10-21S1
Wk 9 · Vol 0.21x
2026-10-20S1
Wk 9 · Vol 0.22x
2026-10-19S1
Wk 8 · Vol 0.31x
2026-10-16S1
Wk 8 · Vol 0.24x
2026-10-15S1
Wk 8 · Vol 0.27x
2026-10-14S1
Wk 8 · Vol 0.38x
2026-10-13S1
Wk 8 · Vol 0.35x
2026-10-12S1
Wk 7 · Vol 0.24x
2026-10-09S1
Wk 7 · Vol 0.28x
2026-10-08S1
Wk 7 · Vol 0.36x
2026-10-07S1
Wk 7 · Vol 0.29x
Moving averages & range
50 DMA
$1.08
200 DMA
$1.22
52W High
$2.11
52W Low
$0.87
5D Low
$0.93
Resistance levels (recent highs)
20d High
$1.10
60d High
$1.29
120d High
$1.39
250d High
$2.11
Next resistance
+17.4%
to 20d High
P/E (TTM)
2.2
Forward 39.0
ROE
+17.6%
Profit margin +28.0%
Dividend Yield
0.00%
P/B 0.4

Organigram Global: quick answers

What stage is Organigram Global in?

As of Oct 22, 2026, Organigram Global (OGI) is in Stage 4, the downtrend phase. It entered Stage 4 on Oct 22, 2026 and is in its first week there. What the four stages mean

Is Organigram Global in an uptrend?

No. Organigram Global is in a Stage 4 downtrend. It trades 23.4% below its 200-day average, which is falling.

How far is Organigram Global from its 52-week high?

Organigram Global closed at $0.94 on Oct 22, 2026, 55.6% below its 52-week high of $2.11. Its 52-week low is $0.87.

How has Organigram Global performed over the past year?

As of Oct 22, 2026, Organigram Global is down 45.5% over the past year and down 45.8% so far in 2026.

Which sector and industry is Organigram Global in?

Organigram Global is in the Drug Manufacturers - Specialty & Generic industry, part of the Health Care sector.

About this companyHealth Care· Drug Manufacturers - Specialty & Generic

Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company is headquartered in Toronto, Canada.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.